In Testicular Feminization syndrome Gonadecto- my is indicated:
Now, the question is about when gonadectomy is indicated. I think the main reason for removing the gonads in this condition is to prevent the risk of developing testicular tumors. Since the testes are in the abdomen or inguinal region in these patients, they are at higher risk for malignant transformation, maybe due to the lack of descent or the condition itself.
The options aren't provided, but the correct answer is likely related to preventing cancer. Let me think of the options. Common distractors might include options about correcting feminization, treating infertility, or managing hormonal imbalances. But the actual indication is the risk of testicular cancer. So the correct answer would be something like "To prevent the risk of developing testicular tumors."
For the wrong options: Option A might say "To correct primary amenorrhea," but that's not the main reason. Option B could be "To treat virilization," but since the patient is resistant to androgens, virilization isn't an issue. Option C might be "To induce puberty," but they would need estrogen therapy instead. Option D is the correct one about cancer prevention.
Clinical pearl: Remember that in complete androgen insensitivity syndrome, the external genitalia are female, but the testes are non-functional and cancerous risk, so gonadectomy is done prophylactically. Also, the patient will need hormone replacement with estrogen to maintain secondary sexual characteristics.
**Core Concept**
Testicular Feminization Syndrome (Complete Androgen Insensitivity Syndrome) involves 46,XY karyotype with non-functional androgen receptors, leading to female external genitalia but absent internal female structures (e.g., uterus). Gonadectomy is a key management step due to malignant potential of undescended testes.
**Why the Correct Answer is Right**
Gonadectomy is indicated **to prevent the risk of developing testicular tumors**, as the non-functional testes in this condition are prone to malignant transformation (e.g., Sertoli-Leydig cell tumors). These testes are typically located in the abdomen or inguinal canal, increasing cancer risk. Early removal reduces this risk and avoids potential virilization from tumor hormones.
**Why Each Wrong Option is Incorrect**
**Option A:** *To correct primary amenorrhea*—Incorrect. Amenorrhea occurs due to absent uterus and ovaries, not testes; hormonal therapy (estrogen) is used, not gonadectomy.
**Option B:** *To treat virilization*—Incorrect. Patients are resistant to androgens, so virilization does not occur.
**Option C:** *To induce puberty*—Incorrect. Puberty is induced via estrogen therapy, not gonadectomy.
**Clinical Pearl / High-Yield Fact**
In Complete Androgen Insensitivity Syndrome, **prophylactic gonadectomy is recommended after puberty** (before malignant transformation risk increases). Distinguish from Partial Androgen Insensitivity